ALIGOS THERAPEUTICS INC (ALGS) Stock Analyst Ratings
USA - NASDAQ:ALGS - US01626L2043 - Common Stock
6.68 USD
-0.21 (-2.98%)
6.68 USD
0 (0%)
ChartMill assigns a Buy % Consensus number of 84% to ALGS. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 88.74. This target is 1228.44% above the current price.
ALGS was analyzed by 10 analysts. The buy percentage consensus is at 84. So analysts seem to be very confident about ALGS.
In the previous month the buy percentage consensus was at a similar level.
ALGS was analyzed by 10 analysts. More opinions would make the average more meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-09-12 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-03-31 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-03-11 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2024-11-07 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-10-23 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-09-20 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-08-19 | HC Wainwright & Co. | Initiate | Buy |
| 2023-01-17 | Piper Sandler | Maintains | Overweight |
| 2023-01-06 | Piper Sandler | Upgrade | Neutral -> Overweight |
| 2023-01-06 | Jefferies | Upgrade | Hold -> Buy |
| 2022-11-03 | SVB Leerink | Maintains | Market Perform |
| 2022-05-05 | SVB Leerink | Downgrade | Outperform -> Market Perform |
| 2022-03-11 | SVB Leerink | Maintains | Outperform |
| 2022-03-11 | Piper Sandler | Maintains | Overweight |
| 2022-02-16 | SVB Leerink | Maintains | Outperform |
| 2022-01-07 | SVB Leerink | Maintains | Outperform |
| 2022-01-07 | JP Morgan | Downgrade | Overweight -> Neutral |
| 2021-09-09 | SVB Leerink | Initiate | Outperform |
ALIGOS THERAPEUTICS INC / ALGS FAQ
What do analysts expect the price target to be for ALIGOS THERAPEUTICS INC (ALGS)?
10 analysts have analysed ALGS and the average price target is 88.74 USD. This implies a price increase of 1228.44% is expected in the next year compared to the current price of 6.68.
How do analysts rate ALIGOS THERAPEUTICS INC (ALGS)?
The consensus rating for ALIGOS THERAPEUTICS INC (ALGS) is 84 / 100 . This indicates that analysts generally have a positive outlook on the stock.